UBS Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $459M | Sell |
|
|||||
|
2025
Q1 | $570M | Sell |
|
|||||
|
2024
Q4 | $445M | Buy |
|
|||||
|
2024
Q3 | $396M | Sell |
|
|||||
|
2024
Q2 | $415M | Sell |
|
|||||
|
2024
Q1 | $643M | Buy |
|
|||||
|
2023
Q4 | $579M | Sell |
|
|||||
|
2023
Q3 | $537M | Sell |
|
|||||
|
2023
Q2 | $590M | Buy |
|
|||||
|
2023
Q1 | $518M | Sell |
|
|||||
|
2022
Q4 | $683M | Buy |
|
|||||
|
2022
Q3 | $612M | Sell |
|
|||||
|
2022
Q2 | $678M | Buy |
|
|||||
|
2022
Q1 | $721M | Sell |
|
|||||
|
2021
Q4 | $746M | Sell |
|
|||||
|
2021
Q3 | $622M | Sell |
|
|||||
|
2021
Q2 | $672M | Sell |
|
|||||
|
2021
Q1 | $611M | Buy |
|
|||||
|
2020
Q4 | $519M | Buy |
|
|||||
|
2020
Q3 | $395M | Sell |
|
|||||
|
2020
Q2 | $488M | Sell |
|
|||||
|
2020
Q1 | $480M | Buy |
|
|||||
|
2019
Q4 | $544M | Buy |
|
|||||
|
2019
Q3 | $445M | Sell |
|
|||||
|
2019
Q2 | $454M | Buy |
|
|||||
|
2019
Q1 | $320M | Buy |
|
|||||
|
2018
Q4 | $307M | Buy |
|
|||||
|
2018
Q3 | $318M | Sell |
|
|||||
|
2018
Q2 | $273M | Buy |
|
|||||
|
2018
Q1 | $244M | Sell |
|
|||||
|
2017
Q4 | $376M | Sell |
|
|||||
|
2017
Q3 | $942M | Buy |
|
|||||
|
2017
Q2 | $895M | Buy |
|
|||||
|
2017
Q1 | $836M | Buy |
|
|||||
|
2016
Q4 | $726M | Buy |
|
|||||
|
2016
Q3 | $576M | Buy |
|
|||||
|
2016
Q2 | $603M | Buy |
|
|||||
|
2016
Q1 | $631M | Buy |
|
|||||
|
2015
Q4 | $572M | Buy |
|
|||||
|
2015
Q3 | $472M | Buy |
|
|||||
|
2015
Q2 | $465M | Buy |
|
|||||
|
2015
Q1 | $432M | Buy |
|
|||||
|
2014
Q4 | $381M | Buy |
|